----

----

----

----

| Nevada                                                              |   | 95-4696799                           |
|---------------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification No.) |

|  Large accelerated filer       ̈         |  Accelerated filer                       ̈ |
|-----------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|
|  Non-accelerated filer         ̈         |  Smaller reporting company   x                                                                                                           |
|  (Do not check if a smaller reporting company)         |                                                                                                                                                    |

----

Table of Contents

IMEDICOR

|                         | Page                                                                                  |
|------------------------------|---------------------------------------------------------------------------------------|
| Part I Financial Information |                                                                                  |
|                         |                                                                                  |   |   |
| Item 1.                      | Financial Statements                                                                  | 3 |
|                         |                                                                                  | Condensed Consolidated Balance Sheet as of March 31, 2011 (unaudited) and June 30, 2010 (audited) | 3 |
|                         |                                                                                  | Condensed Consolidated Statements of Operations for the Three and Nine Months Ended March 31, 2011 and 2010 (unaudited) | 4 |
|                         |                                                                                  | Condensed Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2011 and 2010 (unaudited) | 6 |
|                         |                                                                                  | Notes to Condensed Consolidated Financial Statements (unaudited) | 7 |
|                         |                                                                                  |   |   |
| Item 2.                      | Management's Discussion and Analysis of Financial Condition and Results of Operations | 9 |
|                         |                                                                                  |   |   |
| Item 3.                      | Quantitative and Qualitative Disclosure About Market Risk                             | 13 |
|                         |                                                                                  |   |   |
| Item 4T.                     | Controls and Procedures                                                               | 13 |
|                         |                                                                                  |   |   |
| Item 5.                      | Other Information                                                                     | 14 |
|                         |                                                                                  |   |   |
| Item 6.                      | Exhibits                                                                              | 14 |
|                         |                                                                                  |   |   |
|                         | Signatures                                                                            | 15 |

----

Table of Contents

ITEM 

IMEDICOR

|                                                                                                                                                                                                                  |   | Mar 31, 2011 |        |   | June 30, 2010 |   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------|-------------|--------|---------------|--------|
|                                                                                                                                                                                                                  |   | (unaudited)  |        |   | (audited)     |   |
| ASSETS                                                                                                                                                                                                                |   |         |        |   |          |   |
| Current assets                                                                                                                                                                                                        |   |         |        |   |          |   |
| Cash and cash equivalents                                                                                                                                                                                             |   | $            | 1,000       |   |          | $      | 86,644 |   |
| Accounts receivable, net of allowance for doubtful accounts of $-0-    at March 31, 2011 and June 30, 2010, respectively                                                                          |   |         | 436,280     |   |          |   | 10,000 |   |
| Prepaid Expenses                                                                                                                                                                                                      |   |         | 12,274      |   |          |   | 6,001 |   |
| Total Current Assets                                                                                                                                                                                                  |   |         | 449,554     |   |          |   | 102,645 |   |
| Property and equipment, net                                                                                                                                                                                           |   |         |        |   |          |   | 8,291 |   |
| Other Assets                                                                                                                                                                                                          |   |         |        |   |          |   |   |   |
| Technology and Medical Software, net                                                                                                                                                                                  |   |         | 3,507,700   |   |          |   | 4,996,785 |   |
|                                                                                                                                                                                                                  |   |         | -           |   |          |   | 4,996,785 |   |
| Total Assets                                                                                                                                                                                                          |   | $            | 3,964,124   |   |          | $      | 5,107,721 |   |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)                                                                                                                                                                  |   |         |        |   |          |   |   |   |
| Current liabilities:                                                                                                                                                                                                  |   |         |        |   |          |   |   |   |
| Notes payable –– banks                                                                                                                                                                                    |   | $            | -           |   |          | $      | 59,181 |   |
| Short-term notes payable                                                                                                                                                                                              |   |         | 3,793,358   |   |          |   | 5,487,120 |   |
| Accounts payable and accrued expenses                                                                                                                                                                                 |   |         | 1,846,881   |   |          |   | 1,791,671 |   |
| Deferred income                                                                                                                                                                                                       |   |         | 52,000      |   |          |   | 60,000 |   |
| Total Current Liabilities                                                                                                                                                                                             |   |         | 5,692,239   |   |          |   | 7,397,972 |   |
| Other long-term liabilities                                                                                                                                                                                           |   |         |        |   |          |   |   |   |
| Long-term notes payable                                                                                                                                                                                               |   |         | -           |   |          |   | 1,271,661 |   |
| Total Liabilities                                                                                                                                                                                                     |   |         | 5,962,239   |   |          |   | 8,669,663 |   |
| Stockholders’ Equity (Deficit)                                                                                                                                                                                  |   |         |        |   |          |   |   |   |
| Preferred stock , par value $.001, authorized 200,000,000 shares. Issued and outstanding -28- shares of Series "A"  and -11- shares of Series "B" as of March 31, 2011, and -0- shares as of June 30, 2010. |   |         | -           |   |          |   | - |   |
| Common stock, par value $.001 per share, authorized 600,000,000 shares. Issued and outstanding:  310,744,847 and 229,082,187 shares at March 31, 2011 and June 30 2010, respectively                             |   |         | 310,745     |   |          |   | 229,082 |   |
| Additional Paid in Capital                                                                                                                                                                                            |   |         | 42,913,455  |   |          |   | 37,849,158 |   |
| Less: Treasury stock, 368,407 shares at both March 31, 2011 and June 30, 2010                                                                                                                                         |   |         | (508,195    | )      |          |   | (508,195 | ) |
| Accumulated deficit                                                                                                                                                                                                   |   |         | (44,444,120 | )      |          |   | (41,131,957 | ) |
| Total Stockholders’ Equity (Deficit)                                                                                                                                                                            |   |         | (1,728,115  | )      |          |   | (3,561,912 | ) |
| Total Liabilities and Stockholders’ Equity (Deficit)                                                                                                                                                            |   | $            | 3,964,124   |   |          | $      | 5,107,721 |   |

----

Table of Contents

IMEDICOR

|                                                    |   | For the three  |        |   | For the three  |   |
|---------------------------------------------------------|--------|----------------|-------------|--------|----------------|--------|
|                                                    |   | months ended   |        |   | months ended   |   |
|                                                    |   | March 31, 2011 |        |   | March 31, 2010 |   |
|                                                    |   | (unaudited)    |        |   | (unaudited)    |   |
|                                                    |   |           |        |   |           |   |
| Revenues:                                               |   | $              | 136,478     |   |           | $      | 5,372 |   |
| Cost of Services                                        |   |           | 2,482       |   |           |   | 1,325 |   |
| Gross Profit                                            |   |           | 133,996     |   |           |   | 4,047 |   |
|                                                    |   |           |        |   |           |   |   |   |
| Expenses:                                               |   |           |        |   |           |   |   |   |
| Consulting, commissions and travel                      |   |           | -           |   |           |   | 16,428 |   |
| Operational fees and expenses                           |   |           | 146,926     |   |           |   | 263,050 |   |
| Professional fees                                       |   |           | 46,597      |   |           |   | 31,850 |   |
| Payroll and related taxes                               |   |           | 245,962     |   |           |   | 230,201 |   |
| Depreciation and amortization                           |   |           | 512,853     |   |           |   | 508,413 |   |
| Production, advertising, brochures and public relations |   |           | 38,274      |   |           |   | 39,508 |   |
| Total Expenses                                          |   |           | 990,612     |   |           |   | 1,089,440 |   |
| Loss before other income/(expenses)                     |   |           | (856,616    | )      |           |   | (1,085,393 | ) |
|                                                    |   |           |        |   |           |   |   |   |
| Other Income/(Expenses):                                |   |           |        |   |           |   |   |   |
| Common shares returned to treasury                      |   |           | -           |   |           |   | 650,000 |   |
| Extinguishment of debt                                  |   |           | -           |   |           |   | 270,000 |   |
| Redemption fee                                          |   |           | -           |   |           |   |          (7,500 | ) |
| Interest expense                                        |   |           | (84,052     | )      |           |   | (114,510 | ) |
| Total Other Income/(Expenses)                           |   |           | (84,052     | )      |           |   | 797,990 | ) |
|                                                    |   |           |        |   |           |   |   |   |
|                                                    |   |           |        |   |           |   |   |   |
| Net loss available to common stockholders               |   | $              | (940,668    | )      |           | $      | (287,403 | ) |
|                                                    |   |           |        |   |           |   |   |   |
| Net loss per share, basis and diluted              |   | $              | (0.00       | )      |           | $      | (0.00 | ) |
|                                                    |   |           |        |   |           |   |   |   |
| Weighted average number of shares, basic and diluted    |   |           | 310,774,827 |   |           |   | 138,785,317 |   |

----

Table of Contents

IMEDICOR

|                                                    |   | For the nine   |        |   | For the nine   |   |
|---------------------------------------------------------|--------|----------------|-------------|--------|----------------|--------|
|                                                    |   | months ended   |        |   | months ended   |   |
|                                                    |   | March 31, 2011 |        |   | March 31, 2010 |   |
|                                                    |   | (unaudited)    |        |   | (unaudited)    |   |
|                                                    |   |           |        |   |           |   |
| Revenues:                                               |   | $              | 481,109     |   |           | $      | 136,786 |   |
| Cost of Services                                        |   |           | 3,990       |   |           |   | 9,262 |   |
| Gross Profit                                            |   |           | 477,119     |   |           |   | 127,524 |   |
|                                                    |   |           |        |   |           |   |   |   |
| Expenses:                                               |   |           |        |   |           |   |   |   |
| Stock Issued for Fees and Services                      |   |           | 545,309     |   |           |   | 611,393 |   |
| Consulting, commissions and travel                      |   |           | 114,401     |   |           |   | 38,615 |   |
| Operational fees and expenses                           |   |           | 392,530     |   |           |   | 608,176 |   |
| Professional fees                                       |   |           | 57,492      |   |           |   | 129,265 |   |
| Payroll and related taxes                               |   |           | 573,501     |   |           |   | 685,921 |   |
| Depreciation and amortization                           |   |           | 1,545,506   |   |           |   | 1,521,277 |   |
| Production, advertising, brochures and public relations |   |           | 62,699      |   |           |   | 125,716 |   |
| Total Expenses                                          |   |           | 3,291,438   |   |           |   | 3,572,144 |   |
| Loss before other income/(expenses)                     |   |           | (2,814,319  | )      |           |   | (3,592,839 | ) |
|                                                    |   |           |        |   |           |   |   |   |
| Other Income/(Expenses):                                |   |           |        |   |           |   |   |   |
|                                                    |   |           |        |   |           |   |   |   |
| Extinguishment of debt                                  |   |           |        |   |           |   | 270,000 |   |
| Extinguishment of Accrued Expenses                 |   |           | 91,511      |   |           |   |  - |   |
| Redemption fee                                          |   |           | -           |   |           |   | (328,792 | )  |
| Interest expense                                        |   |           | (403,355    | )      |           |   | (325,659 | ) |
| Total Other Income/(Expenses)                           |   |           | (311,844    | )      |           |   | (384,451 | ) |
|                                                    |   |           |        |   |           |   |   |   |
| Net loss available to common stockholders               |   | $              | (3,312,163  | )      |           | $      | (3,977,290 | ) |
|                                                    |   |           |        |   |           |   |   |   |
| Net loss per share, basic and diluted                   |   | $              | (0.01       | )      |           | $      | (0.03 | ) |
|                                                    |   |           |        |   |           |   |   |   |
| Weighted average number of shares, basic and diluted    |   |           | 304,659,743 |   |           |   | 130,118,307 |   |

----

Table of Contents

IMEDICOR

|                                          |   | For the nine   |       |    | For the nine   |   |
|-----------------------------------------------|--------|----------------|------------|---------|----------------|--------|
|                                          |   | months ended   |       |    | months ended   |   |
|                                          |   | March 31, 2011 |       |    | March 31, 2010 |   |
|                                          |   | unaudited      |       |    | unaudited      |   |
| Cash Flows From Operating Activities:         |   |           |       |    |           |   |
| Receipts from customers                       |   | $              | 46,829     |    |           | $      | 75,166 |   |
| Payments to suppliers, salaries               |   |           | (1,064,165 | )       |           |   | (1,363,892 | ) |
| Interest paid                                 |   |           | (196,424   | )       |           |   | (47,386 | ) |
| Net Cash Used in Operating Activities         |   |           | (1,213,760 | )       |           |   | (1,336,112 | ) |
|                                          |   |           |       |    |           |   |   |   |
| Cash Flows Used in Investing Activities:      |   |           |       |    |           |   |   |   |
| Purchase of Technology & Medical Software |   |           | (55,000    | )  |           |   | (180,000 | ) |
| Net Cash Used in Investing Activities         |   |           | (55,000    | )  |           |   | (180,000 | ) |
|                                          |   |           |       |    |           |   |   |   |
| Cash Flows From Financing Activities:         |   |           |       |    |           |   |   |   |
| Payments on bank loan                         |   |           | (59,181    | )  |           |   | (14,087 |   |
| Payments on notes payable                     |   |           | (15,000    | )       |           |   | (25,000 | ) |
| Short term loans proceeds                     |   |           | 773,297    |    |           |   | 1,509,328 |   |
| Sale of common stock                          |   |           | 484,000    |    |           |   | - |   |
| Net Cash Provided by Financing Activities     |   |           | 1,183,116  |    |           |   | 1,470,241 |   |
|                                          |   |           |       |    |           |   |   |   |
| Net Increase/(Decrease) in Cash               |   |           | (85,644    | )       |           |   | (45,871 | ) |
|                                          |   |           |       |    |           |   |   |   |
| Cash at the Beginning of Period               |   |           | 86,644     |    |           |   | 52,615 |   |
|                                          |   |           |       |    |           |   |   |   |
| Cash at End of Period                         |   | $              | 1,000      |    |           | $      | 6,744 |   |

| Reconciliation of Net Loss to Net Cash:   Used by Operating Activities |   |   |       |    |   |   |
|---------------------------------------------------------------------------------------|--------|--------|------------|---------|--------|--------|
| Net Loss                                                                              |   | $      | (3,126,163 | )  |   | $      | (3,977,290 | ) |
| Adjustments to reconcile net income/(loss) to net cash                                |   |   |       |    |   |   |   |   |
| Used by operating activities                                                          |   |   |       |    |   |   |   |   |
| Depreciation & Amortization                                                       |   |   | 1,545,506  |    |   |   | 1,521,277 |   |
| Shares issued in exchange for services                                                |   |   | 545,309    |    |   |   | 611,393 |   |
| Other income – Extinguishment of debt                                           |   |   | (91,511    | )  |   |   | (270,000 |   |
| Loan accretion                                                                        |   |   | -          |    |   |   | 328,792 |   |
| Changes in:                                                                           |   |   |       |    |   |   |   |   |
| Trade Receivables                                                                     |   |   | (426,280   | )       |   |   |   |   |
| Advance                                                                               |   |   | (6,723     | )       |   |   |   |   |
| Accounts payable and accrued expenses                                                 |   |   | 146,721    |    |   |   | 236,776 |   |
| Accrued interest                                                                      |   |   | 206,931    |    |   |   | 274,560  |   |
| Deferred income                                                                       |   |   | (8,000     | )  |   |   | (61,620 |   |
| Net Cash Used by Operating Activities                                                 |   |   | (1,213,760 | )       |   |   | (1,336,112 | ) |

----

Table of Contents

IMEDICOR

| No. Shares           |       |   |       |   |              |           |   |
|----------------------|------------|--------|------------|--------|-------------------|----------------|--------|
| Issuable on Exercise |       |   | Expiration |   |              | Exercise Price |   |
|                 | 1,239,999  |   |       |   | 2011              |           |   | $ | 0.60 |   |
|                 | 1,430,000  |   |       |   | 2011              |           |   | $ | 0.24 |   |
|                 | 1,541,667  |   |       |   | 2011              |           |   | $ | 0.12 |   |
|                 | 4,000,000  |   |       |   | 2013              |           |   | $ | 0.04 |   |
|                 | 13,640,000 |   |       |   | 2013              |           |   | $ | 0.03 |   |
|                 | 16,160,000 |   |       |   | 2013 – 2015 |           |   | $ | 0.05 |   |
|                 |       |   |       |   |              |           |   |   |   |   |

----

Table of Contents

|                                                   |   | 03/31/2011 |       |   | 6/30/2010 |   |
|--------------------------------------------------------|--------|------------|------------|--------|-----------|--------|
| Technology and medical software                        |   | $          | 10,293,893 |   |      | $      | 10,238,892 |   |
| Less: Accumulated Amortization     |   |       | 6,786,193  |   |      |   | 5,242,107 |   |
|                                                   |   | $          | 3,507,700  |   |      | $      | 4,996,785 |   |

|                   |   |   | 03/31/2011 |   |
|------------------------|--------|--------|------------|--------|
| Convertible Debentures |   | $      | 3,172,803  |   |
| Notes Payable          |   |   | 622,555    |   |
| Total                  |   | $      | 3,795,358  |   |

----

Table of Contents

ITEM 

----

Table of Contents

|                                            |   | Three Months Ended March 31 |      |
|-------------------------------------------------|--------|-----------------------------|-----------|
|                                            |   | (unaudited)                 |      |
|                                            |   | 2011                        |      |   | 2010 |   |
| Net Sales and Revenues                          |   | $                           | 136,478   |   |   | $ | 5,372 |   |
| Cost of Services                                |   |                        | 2,482     |   |   |   | 1,325 |   |
| Gross Profit                                    |   |                        | 133,996   |   |   |   | 4,047 |   |
|                                            |   |                        |      |   |   |   |   |   |
| Operational General and Administrative Expenses |   |                        | 477,759   |   |   |   | 581,027 |   |
| Depreciation and amortization                   |   |                        | 512,853   |   |   |   | 508,413 |   |
| Total Expenses                                  |   |                        | 960,612   |   |   |   | 1,089,440 |   |
| Loss before other income (expense)              |   | $                           | (856,616) |   |   | $ | (1,085,393 | ) |

----

Table of Contents

|                                            |   | Nine Months Ended March 31 |        |
|-------------------------------------------------|--------|----------------------------|-------------|
|                                            |   | (unaudited)                |        |
|                                            |   | 2011                       |        |   | 2010 |   |
| Net Sales and Revenues                          |   | $                          | 481,109     |   |   | $ | 136,786 |   |
| Cost of Services                                |   |                       | 3,990       |   |   |   | 9,262 |   |
| Gross Profit                                    |   |                       | 477,119     |   |   |   | 127,524 |   |
|                                            |   |                       |        |   |   |   |   |   |
| Operational General and Administrative Expenses |   |                       | 1,200,623   |   |   |   | 1,587,693 |   |
| Depreciation and amortization                   |   |                       | 1,545,506   |   |   |   | 1,521,277 |   |
| Stock issued for fees and services              |   |                       | 545,309     |   |   |   | 611,393 |   |
| Total Expenses                                  |   |                       | 3,291,438   |   |   |   | 3,720,363 |   |
| Loss before other income (expense)              |   | $                          | (2,814,319) |   |   | $ | (3,592,839) |   |

----

Table of Contents

----

Table of Contents

ITEM 

ITEM 

----

Table of Contents

ITEM 

ITEM 

| 4.1       |         | Secured Convertible Promissory Note of the Company dated April 18, 2009*                                                                                                                             |
|-----------|--------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|      |         |                                                                                                                                                                                                 |
| 4.2       |    | Modification Agreement dated March 31, 2011**                                                                                                                                                        |
|      |         |                                                                                                                                                                                                 |
| 4.3       |         | Secured Convertible Promissory Note dated March 31, 2011**                                                                                                                                           |
|      |         |                                                                                                                                                                                                 |
| 4.4       |         | Series “A” Preferred Stock Description**                                                                                                                                                 |
|      |         |                                                                                                                                                                                                 |
| 4.5  |         | Series "B" Preferred Stock Subscription Agreement**                                                                                                                                                  |
|      |         |                                                                                                                                                                                                 |
| 4.6  |         | Series “B” Preferred Stock Description**                                                                                                                                                 |
|      |         |                                                                                                                                                                                                 |
| 4.7       |         |                                                                                                                                                                                                 |
|      |         |                                                                                                                                                                                                 |
| 31.1      |         | Certification of the President and Chief Executive Officer pursuant to Rule 13a-14(a).                                                                                                               |
|      |         |                                                                                                                                                                                                 |
| 31.2      |         | Certification of the Chief Financial Officer and Treasurer pursuant to Rule 13a-14(a).                                                                                                               |
|      |         |                                                                                                                                                                                                 |
| 32        |         | Certification of the President and Chief Executive Officer and Chief Financial Officer and Treasurer pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002. |

----

Table of Contents

SIGNATURES

|               | IMedicor, Inc.(Registrant) |                                                               |
|--------------------|----------------------------|--------------------------------------------------------------------|
|               |                       |                                                               |   |
| Date: May 23, 2011 | By:                        | /s/ Fred Zolla                                                |   |
|               |                       | Fred Zolla                                                         |   |
|               |                       | President and Chief Executive Officer(Principal Executive Officer) |   |
|               |                       |                                                               |   |

| Date: May 23, 2011 | By:    | /s/ Craig Stout                                          |   |
|--------------------|--------|---------------------------------------------------------------|--------|
|               |   | Craig Stout                                                   |   |
|               |   | Interim Chief Financial Officer(Principal Accounting Officer) |   |
|               |   |                                                          |   |

----

Table of Contents